Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode

DSpace Repository

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode

Author: Gillissen, B.; Richter, A.; Richter, A.; Overkamp, T.; Essmann, F.; Hemmati, P. G.; Preissner, R.; Belka, C.; Daniel, P. T.
Tübinger Autor(en):
Essmann, Frank
Published in: Cell Death & Disease (2013), Bd. 4, Article e643
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/cddis.2013.67
ISSN: 2041-4889
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)